Sarode, P.; Schaefer, M. B.; Grimminger, F.; Seeger, W.; Savai, R.: Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk. FRONTIERS IN ONCOLOGY 10, 324 (2020)
Zheng, X.; Weigert, A.; Reu, S.; Guenther, S.; Mansouri, S.; Bassaly, B.; Gattenlohner, S.; Grimminger, F.; Pullamsetti, S. S.; Seeger, W.et al.; Winter, H.; Savai, R.: Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma. CANCER RESEARCH 80 (20), pp. 4414 - 4425 (2020)
Saqib, U.; Savai, R.; Liu, D.; Banerjee, S.; Baig, M. S.: Drug repositioning as an effective therapy for protease-activated receptor 2 inhibition. JOURNAL OF CELLULAR BIOCHEMISTRY 120 (2), pp. 1522 - 1526 (2019)
Brunn, D.; Grimminger, F.; Seeger, W.; Savai, R.: Interferon Regulatory Factor 9 Mediated Regulation of Lung Cancer Progression and Metastasis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 197 (2018)
Pullamsetti, S. S.; Seeger, W.; Savai, R.: Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension. JOURNAL OF CLINICAL INVESTIGATION 128 (5), pp. 1720 - 1723 (2018)
Saqib, U.; Kelley, T. T.; Panguluri, S. K.; Liu, D.; Savai, R.; Baig, M. S.; Schurer, S. C.: Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets. FRONTIERS IN PHARMACOLOGY 9, 1201 (2018)
Turkowski, K.; Haselbauer, T.; Kaduthanam, S.; Sueltmann, H.; Grimminger, F.; Seeger, W.; Savai, R.: Macrophage and Cancer Cell Crosstalk Regulated MicroRNA 147b Plays a Crucial Role in Lung Cancer Progression. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 197 (2018)
Kiehl, S.; Zimmermann, T.; Savai, R.; Pullamsetti, S. S.; Seeger, W.; Bartkuhn, M.; Dammann, R. H.: Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer. SCIENTIFIC REPORTS 7, 3896 (2017)
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).
Institutions from the Rhine-Main region have come together in Frankfurt's Römer to form a new science network. The future cooperation in the "Frankfurt Alliance" was sealed with the signing of a Memorandum of Understanding. The Max Planck Institute for Heart and Lung Research is one of the founding members of the new scientific alliance.